DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Micardis (Telmisartan) - Adverse Event Reports - Disability

 



Index of reports > Cases resulting in disability (37)

     Cerebral Infarction (11)Pulmonary Alveolar Haemorrhage (3)Subarachnoid Haemorrhage (3)Interstitial Lung Disease (3)Dialysis (3)Pneumothorax (3)Jaundice (2)Malaise (2)Iiird Nerve Paralysis (2)Asthenia (2)

Below is the selection of adverse event reports related to Micardis (Telmisartan) that includes cases resulting in disability.

 Reports 1 - 25 of 37   Next >>

Adverse event in male receiving Micardis (Telmisartan)

Reported by a consumer/non-health professional from United States on 2007-10-29

Patient: male

Adverse reactions / side effects: Hypoacusis, Deafness Unilateral

Adverse event resulted in: disablity

Suspect drug(s):
Micardis (Telmisartan)



Adverse event in male receiving Micardis (Telmisartan)

Reported by a individual with unspecified qualification from Japan on 2007-10-25

Patient: male, weighing 58.0 kg (127.6 pounds)

Adverse reactions / side effects: Renal Failure Chronic

Adverse event resulted in: disablity

Suspect drug(s):
Micardis (Telmisartan)

Other drugs received by patient: Candesartan Cilexetil; Doxazosin Mesylate; Artist; Ticlopidine HCL; Norvasc; Adalat



Adverse event in male receiving Micardis (Telmisartan)

Reported by a individual with unspecified qualification from Japan on 2007-10-25

Patient: male, weighing 52.0 kg (114.4 pounds)

Adverse reactions / side effects: Cerebral Infarction

Adverse event resulted in: hospitalization, disablity

Suspect drug(s):
Micardis (Telmisartan)

Other drugs received by patient: Amaryl; Basen



Adverse event in male receiving Micardis (Telmisartan)

Reported by a individual with unspecified qualification from Japan on 2007-10-22

Patient: male, weighing 52.0 kg (114.4 pounds)

Adverse reactions / side effects: Cerebral Infarction

Adverse event resulted in: hospitalization, disablity

Suspect drug(s):
Micardis (Telmisartan)

Other drugs received by patient: Amaryl; Basen



Adverse event in male receiving Micardis (Telmisartan)

Reported by a individual with unspecified qualification from Japan on 2007-10-18

Patient: male, weighing 70.0 kg (154.0 pounds)

Adverse reactions / side effects: Dialysis

Adverse event resulted in: hospitalization, disablity

Suspect drug(s):
Micardis (Telmisartan)

Other drugs received by patient: Norvasc; Amaryl



Adverse event in male receiving Micardis (Telmisartan)

Reported by a individual with unspecified qualification from Japan on 2007-10-18

Patient: male, weighing 70.0 kg (154.0 pounds)

Adverse reactions / side effects: Dialysis

Adverse event resulted in: hospitalization, disablity

Suspect drug(s):
Micardis (Telmisartan)

Other drugs received by patient: Norvasc; Amaryl



Adverse event in male receiving Micardis (Telmisartan)

Reported by a individual with unspecified qualification from Japan on 2007-10-18

Patient: male, weighing 70.0 kg (154.0 pounds)

Adverse reactions / side effects: Dialysis

Adverse event resulted in: hospitalization, disablity

Suspect drug(s):
Micardis (Telmisartan)

Other drugs received by patient: Norvasc; Amaryl



Adverse event in 71 year old female receiving Micardis (Telmisartan)

Reported by a physician from France on 2007-10-02

Patient: 71 year old female

Adverse reactions / side effects: Muscle Haemorrhage

Adverse event resulted in: disablity

Suspect drug(s):
Micardis (Telmisartan)

Other drugs received by patient: Simvastatin; Evista; Levothyrox



Adverse event in female receiving Micardis (Telmisartan)

Reported by a individual with unspecified qualification from Japan on 2007-10-02

Patient: female, weighing 73.0 kg (160.6 pounds)

Adverse reactions / side effects: Cerebral Haemorrhage

Adverse event resulted in: life threatening event, hospitalization, disablity

Suspect drug(s):
Micardis (Telmisartan)

Other drugs received by patient: Inderal LA; Thyradin S; Simvastatin; Dibetos B; Amlodipine; Phenobarbital TAB; Novorapid; Novolin N



Adverse event in male receiving Micardis (Telmisartan)

Reported by a individual with unspecified qualification from Japan on 2007-07-13

Patient: male, weighing 86.0 kg (189.2 pounds)

Adverse reactions / side effects: Vitreous Haemorrhage

Adverse event resulted in: hospitalization, disablity

Suspect drug(s):
Micardis (Telmisartan)



Adverse event in male receiving Micardis (Telmisartan)

Reported by a individual with unspecified qualification from Japan on 2007-07-10

Patient: male, weighing 86.0 kg (189.2 pounds)

Adverse reactions / side effects: Vitreous Haemorrhage

Adverse event resulted in: hospitalization, disablity

Suspect drug(s):
Micardis (Telmisartan)

Other drugs received by patient: Amiyu (Mixed Amino Acid Preparations); Persantin



Adverse event in male receiving Micardis (Telmisartan)

Reported by a physician from Japan on 2007-06-20

Patient: male, weighing 64.0 kg (140.8 pounds)

Adverse reactions / side effects: Interstitial Lung Disease, Pulmonary Alveolar Haemorrhage, Pneumothorax

Adverse event resulted in: hospitalization, disablity

Suspect drug(s):
Micardis
    Administration route: Oral
    Indication: Hypertension
    Start date: 2004-01-01
    End date: 2006-11-15

Tenormin
    Administration route: Oral
    Indication: Hypertension
    Start date: 2004-01-01
    End date: 2006-11-15

Norvasc
    Administration route: Oral
    Indication: Hypertension
    Start date: 2004-01-01
    End date: 2006-11-15



Adverse event in male receiving Micardis (Telmisartan)

Reported by a physician from Japan on 2007-06-18

Patient: male, weighing 64.0 kg (140.8 pounds)

Adverse reactions / side effects: Interstitial Lung Disease, Pulmonary Alveolar Haemorrhage, Pneumothorax

Adverse event resulted in: hospitalization, disablity

Suspect drug(s):
Micardis
    Administration route: Oral
    Indication: Hypertension
    Start date: 2004-01-01
    End date: 2006-11-15

Tenormin
    Administration route: Oral
    Indication: Hypertension
    Start date: 2004-01-01
    End date: 2006-11-15

Norvasc
    Administration route: Oral
    Indication: Hypertension
    Start date: 2004-01-01
    End date: 2006-11-15



Adverse event in male receiving Micardis (Telmisartan)

Reported by a individual with unspecified qualification from United States on 2007-06-13

Patient: male, weighing 75.0 kg (165.0 pounds)

Adverse reactions / side effects: Oesophagitis, Anaemia

Adverse event resulted in: hospitalization, disablity

Suspect drug(s):
Aggrenox
    Dosage: 1 capsule twice daily
    Administration route: Oral
    Indication: Cerebrovascular Accident Prophylaxis
    Start date: 2004-10-26
    End date: 2005-11-05

Micardis
    Dosage: 1 tablet daily
    Administration route: Oral
    Indication: Cerebrovascular Accident Prophylaxis
    Start date: 2004-10-26
    End date: 2005-11-05

Clopidogrel
    Dosage: 1 tablet daily
    Administration route: Oral
    Indication: Cerebrovascular Accident Prophylaxis
    Start date: 2004-10-26
    End date: 2005-11-05



Adverse event in male receiving Micardis (Telmisartan)

Reported by a physician from Japan on 2007-05-23

Patient: male, weighing 64.0 kg (140.8 pounds)

Adverse reactions / side effects: Interstitial Lung Disease, Pulmonary Alveolar Haemorrhage, Pneumothorax

Adverse event resulted in: hospitalization, disablity

Suspect drug(s):
Micardis
    Administration route: Oral
    Indication: Hypertension
    Start date: 2004-01-01
    End date: 2006-11-15

Tenormin
    Administration route: Oral
    Indication: Hypertension
    Start date: 2004-01-01
    End date: 2006-11-15

Norvasc
    Administration route: Oral
    Indication: Hypertension
    Start date: 2004-01-01
    End date: 2006-01-15

Other drugs received by patient: Flomox; Kirpres; Mucosolvan; Medicon



Adverse event in male receiving Micardis (Telmisartan)

Reported by a physician on 2007-05-22

Patient: male

Adverse reactions / side effects: Contusion, Pain, Dizziness, Gait Disturbance, Aneurysm, Fall

Adverse event resulted in: disablity

Suspect drug(s):
Micardis
    Start date: 2006-11-09

Flomax

Other drugs received by patient: Crestor; Serc; Temazepam; Tylenol W / Codeine NO. 4



Adverse event in male receiving Micardis (Telmisartan)

Reported by a consumer/non-health professional on 2007-05-04

Patient: male

Adverse reactions / side effects: Contusion, Pain, Gait Disturbance, Aneurysm

Adverse event resulted in: disablity

Suspect drug(s):
Micardis (Telmisartan)



Adverse event in female receiving Micardis (Telmisartan)

Reported by a individual with unspecified qualification from Japan on 2007-04-24

Patient: female, weighing 54.0 kg (118.8 pounds)

Adverse reactions / side effects: Subarachnoid Haemorrhage

Adverse event resulted in: hospitalization, disablity

Suspect drug(s):
Micardis (Telmisartan)

Other drugs received by patient: Calblock



Adverse event in female receiving Micardis (Telmisartan)

Reported by a individual with unspecified qualification from Japan on 2007-04-18

Patient: female, weighing 54.0 kg (118.8 pounds)

Adverse reactions / side effects: Subarachnoid Haemorrhage

Adverse event resulted in: hospitalization, disablity

Suspect drug(s):
Micardis (Telmisartan)

Other drugs received by patient: Calblock



Adverse event in female receiving Micardis (Telmisartan)

Reported by a individual with unspecified qualification from Japan on 2007-04-09

Patient: female, weighing 54.0 kg (118.8 pounds)

Adverse reactions / side effects: Subarachnoid Haemorrhage

Adverse event resulted in: hospitalization, disablity

Suspect drug(s):
Micardis (Telmisartan)

Other drugs received by patient: Calblock



Adverse event in 48 year old male receiving Micardis (Telmisartan)

Reported by a physician from Japan on 2007-03-23

Patient: 48 year old male

Adverse reactions / side effects: Gastrointestinal Haemorrhage, Renal Impairment

Adverse event resulted in: death, disablity

Suspect drug(s):
Baraclude
    Administration route: Oral
    Indication: Hepatitis B
    Start date: 2006-12-05
    End date: 2007-01-08

Micardis
    Administration route: Oral
    Indication: Hypertension
    Start date: 2006-09-05
    End date: 2006-12-19

Prednisolone
    Administration route: Oral
    Indication: Graft Versus Host Disease
    Start date: 2006-02-03
    End date: 2007-01-08

Allopurinol
    Administration route: Oral
    Indication: Hyperuricaemia
    Start date: 2006-09-05
    End date: 2006-12-19

Slow-K
    Administration route: Oral
    Indication: Hypokalaemia
    Start date: 2006-09-13
    End date: 2006-12-19

Lasix
    Administration route: Oral
    Indication: Renal Disorder
    Start date: 2006-09-05
    End date: 2007-01-08



Adverse event in male receiving Micardis (Telmisartan)

Reported by a individual with unspecified qualification from Japan on 2007-03-05

Patient: male, weighing 49.0 kg (107.8 pounds)

Adverse reactions / side effects: Cerebral Infarction

Adverse event resulted in: hospitalization, disablity

Suspect drug(s):
Micardis (Telmisartan)



Adverse event in 71 year old female receiving Micardis (Telmisartan)

Reported by a physician from France on 2007-03-05

Patient: 71 year old female

Adverse reactions / side effects: Muscle Haemorrhage

Adverse event resulted in: disablity

Suspect drug(s):
Micardis (Telmisartan)

Other drugs received by patient: Simvastatin; Evista; Levothyroxine Sodium



Adverse event in male receiving Micardis (Telmisartan)

Reported by a individual with unspecified qualification from Japan on 2007-02-28

Patient: male, weighing 49.0 kg (107.8 pounds)

Adverse reactions / side effects: Cerebral Infarction

Adverse event resulted in: hospitalization, disablity

Suspect drug(s):
Micardis (Telmisartan)



Adverse event in male receiving Micardis (Telmisartan)

Reported by a individual with unspecified qualification from Japan on 2007-02-20

Patient: male, weighing 49.0 kg (107.8 pounds)

Adverse reactions / side effects: Cerebral Infarction

Adverse event resulted in: hospitalization, disablity

Suspect drug(s):
Micardis (Telmisartan)



 Page 1   Next >>

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009